spiperone has been researched along with Muscular Atrophy in 1 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "[3H]Spiperone binding was investigated in the caudate nucleus, substantia nigra (s." | 5.26 | Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. ( Bannister, R; Mackay, AV; Quik, M; Spokes, EG, 1979) |
| "[3H]Spiperone binding was investigated in the caudate nucleus, substantia nigra (s." | 1.26 | Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. ( Bannister, R; Mackay, AV; Quik, M; Spokes, EG, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quik, M | 1 |
| Spokes, EG | 1 |
| Mackay, AV | 1 |
| Bannister, R | 1 |
1 other study available for spiperone and Muscular Atrophy
| Article | Year |
|---|---|
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Topics: Binding Sites; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Frontal Lobe; Humans; Levodopa; Mus | 1979 |